Only registred members can create thier own customized alerts.
-
13/02/12
Xenetic Biosciences doses its first intravenous patient with ErepoXen -
01/02/12
Xenetic Biosciences suspends open offer part of fundraising -
23/01/12
Xenetic dismisses SIL stake sale report -
04/01/12
Xenetic threatens to scrap SymbioTec acquisition -
15/12/11
Xenetic Biosciences reports slight delay in completing German acquisition